ANGO Angiodynamics Inc

Price (delayed)

$9.29

Market cap

$364.51M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.94

Enterprise value

$384.2M

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include ...

Highlights
The revenue has increased by 9% year-on-year and by 2.1% since the previous quarter
ANGO's gross profit is up by 8% year-on-year
ANGO's net income is down by 14% since the previous quarter but it is up by 6% year-on-year
The quick ratio has decreased by 13% YoY but it has increased by 3.6% QoQ
The company's debt has surged by 99% YoY
Angiodynamics's equity has decreased by 7% YoY and by 2.5% from the previous quarter

Key stats

What are the main financial stats of ANGO
Market
Shares outstanding
39.24M
Market cap
$364.51M
Enterprise value
$384.2M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.91
Price to sales (P/S)
1.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.15
Earnings
Revenue
$334.68M
EBIT
-$37.31M
EBITDA
-$3.82M
Free cash flow
-$18.77M
Per share
EPS
-$0.94
Free cash flow per share
-$0.48
Book value per share
$10.16
Revenue per share
$8.47
TBVPS
$5.29
Balance sheet
Total assets
$542.85M
Total liabilities
$145.19M
Debt
$49.81M
Equity
$397.66M
Working capital
$82.94M
Liquidity
Debt to equity
0.13
Current ratio
2.19
Quick ratio
1.16
Net debt/EBITDA
-5.15
Margins
EBITDA margin
-1.1%
Gross margin
52.1%
Net margin
-11.1%
Operating margin
-10.5%
Efficiency
Return on assets
-6.7%
Return on equity
-9.1%
Return on invested capital
-24.5%
Return on capital employed
-7.9%
Return on sales
-11.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANGO stock price

How has the Angiodynamics stock price performed over time
Intraday
-0.85%
1 week
-3.53%
1 month
12.06%
1 year
-51.36%
YTD
-32.53%
QTD
-10.15%

Financial performance

How have Angiodynamics's revenue and profit performed over time
Revenue
$334.68M
Gross profit
$174.34M
Operating income
-$35.24M
Net income
-$37.24M
Gross margin
52.1%
Net margin
-11.1%
The company's operating margin rose by 24% YoY but it fell by 9% QoQ
ANGO's operating income is up by 16% year-on-year but it is down by 11% since the previous quarter
The company's net margin rose by 15% YoY but it fell by 11% QoQ
ANGO's net income is down by 14% since the previous quarter but it is up by 6% year-on-year

Growth

What is Angiodynamics's growth rate over time

Valuation

What is Angiodynamics stock price valuation
P/E
N/A
P/B
0.91
P/S
1.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.15
Angiodynamics's EPS has decreased by 13% from the previous quarter but it has increased by 8% YoY
The P/B is 43% less than the last 4 quarters average of 1.6 and 39% less than the 5-year quarterly average of 1.5
Angiodynamics's equity has decreased by 7% YoY and by 2.5% from the previous quarter
The P/S is 58% less than the 5-year quarterly average of 2.6 and 45% less than the last 4 quarters average of 2.0
The revenue has increased by 9% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Angiodynamics business performance
ANGO's ROIC is up by 33% YoY but it is down by 6% QoQ
Angiodynamics's ROS has increased by 23% YoY but it has decreased by 7% from the previous quarter
The ROE is down by 17% since the previous quarter
ANGO's ROA is down by 14% since the previous quarter but it is up by 7% year-on-year

Dividends

What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANGO.

Financial health

How did Angiodynamics financials performed over time
The company's total liabilities rose by 28% YoY but it fell by 3.4% QoQ
ANGO's current ratio is down by 15% year-on-year
The company's debt is 87% lower than its equity
The debt to equity has soared by 117% YoY and by 8% from the previous quarter
The company's debt has surged by 99% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.